Nutritional Compounds: Can They Have An Impact With Diabetic Neuropathy?
- Volume 21 - Issue 3 - March 2008
- 6232 reads
- 0 comments
Diabetic neuropathies are a consequence of long-term hyperglycemia and occur in patients with type 2 diabetes, usually those who are 40 years of age or older. Diabetic neuropathy may occur regardless of whether a patient has insulin-dependent or non-insulin dependent diabetes.
Bear in mind that diabetic neuropathy may have a variety of clinical characteristics. Patients may have a symmetric or asymmetric presentation. They may have sensory or autonomic neuropathy. You may note a mononeuropathic or ployneuropathic presentation. Some patients may have entrapment neuropathies while others do not.
Many patients have mixed varieties of neuropathy involving the sensory nerves of the distal limbs and the autonomic nervous system. Many of the sensory neuropathies involve pain and patients frequently describe the pain as burning and numbness. These symptoms interfere with sleep, daily activities and quality of life.
Researchers have proposed many theories to explain the chronic complications of diabetes mellitus (DM). The first is that a high level of intracellular glucose leads to nonenzymatic glycosylation of protein molecules from the interaction of glucose with amino groups, forming advanced glycosylation end products (AGEs). The second hypothesis is that chronic high levels of glucose result in excessive metabolism via the sorbitol pathway.
A third theory is that hyperglycemia increases oxidative stress and free radical generation. One study examined this hypothesis by evaluating the effect of alpha-tocopherol depletion in normal and streptozotocin-induced diabetic rats with peripheral nerve neuropathy. Authors say their data “highlight the importance of reactive oxygen species in the etiology of impaired nerve maturation and regeneration in experimental diabetes, and indirectly support the view that antioxidant treatment could have a therapeutic role in patients.”1
While the treatment of diabetic neuropathy has improved with the application of antiepileptic drugs and antidepressants, it still remains frustrating. Most of the commonly used medications have anticholinergic side effects or cause sedation. They also only treat the symptoms and not the underlying cause of the neuropathy.
With this in mind, we conducted a study to determine if we could improve patients’ reports of pain and numbness by utilizing nutritional supplements that may partially address the causes of diabetic complications.
A Closer Look At The Study
We selected one supplement with five nutritional compounds on the basis of their activity and application to the aforementioned theories of diabetic complications.
NeuropathyRX (Neuropathy Solutions) contains N-acetyl-cysteine (NAC), alpha-lipoic-acid (ALA), L-carnitine (LCA), vitamin C and selenium. N-acetyl-cysteine is a reducing agent, a potent antioxidant and serves as a major precursor to the antioxidant glutathione. It also protects the kidneys from contrast-induced nephropathy.2 Glutathione also appears to reverse the early effects of glycosylation and subsequently the formation of AGEs.3
Alpha-lipoic-acid is a potent antioxidant involved in metabolic reactions in the mitochondria and energy production. In animal models of diabetes, it reverses the decrease in nerve blood flow.4 L-carnitine helps correct elevated sorbitol levels in rat models of diabetes.5 Selenium is a potent antioxidant that works synergistically with vitamin E. Vitamin C is the most important water-soluble antioxidant. It scavenges both nitrogen and oxygen reactive species. It may also have a beneficial effect on the production of sorbitol and its metabolites in the hyperglycemic state.6
This was an open-label study. We selected patients from a practice of podiatrists. We enrolled patients who complained of neuropathy symptoms despite maximum medical therapy. Out of the 30 patients who enrolled, 28 completed the six-month study. The average age was 68 with an age range from 48 to 94. Twelve patients were men and 16 patients were women. Most patients had comorbid conditions including hypertension, obesity and hyperlipidemia.